3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Primary Myelofibrosis
13
Myeloproliferative Disorders
9
Leukemia, Myeloid, Acute
8
Thrombocythemia, Essential
6
Polycythemia Vera
6
Myelodysplastic Syndromes
5
Lymphoma, T-Cell
4
Leukemia
4
Recurrence
3
Neoplasms
3
Graft vs Host Disease
3
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma
2
Leukemia, Prolymphocytic, T-Cell
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Hematologic Neoplasms
2
Uveal Melanoma
1
Thalassemia
1
Targeted Therapy
1
Prostatic Neoplasms
1
Preleukemia
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Neoplasms by Histologic Type
1
Mycosis Fungoides
1
Multiple Myeloma
1
Mesothelioma
1
Melanoma
1
Lymphoma, T-Cell, Peripheral
1
Interventions
Cisplatin
11
pembrolizumab
10
Carboplatin
7
Radiotherapy
6
Cetuximab
6
Docetaxel
5
Surveys and Questionnaires
3
Radiotherapy, Intensity-Modulated
3
Paclitaxel
3
Cyclophosphamide
3
fludarabine
2
cemiplimab
2
atezolizumab
2
aldesleukin
2
Surgical Procedures, Operative
2
Standard of Care
2
Radiation
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Fluorouracil
2
Drug Therapy
2
vistusertib
1
toripalimab
1
sitravatinib
1
palbociclib
1
osimertinib
1
olaparib
1
niraparib
1
lenvatinib
1
fludarabine phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Squamous Cell
×
ruxolitinib
×
90 days
×
Clear all
No trials found.